AN1 0.00% 0.8¢ anagenics limited

Funny reading all the trolls who are so sure this test is of no...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,209 Posts.
    lightbulb Created with Sketch. 3267
    Funny reading all the trolls who are so sure this test is of no use. They all focus on early detection but overlook the fact that even PCR testing has limited early accuracy.

    Another key here is that pathology labs have limited capacity and each test costs a chunk of money to collect and process. The govt are throwing billions at stimulating a damaged economy. To test the entire population with a $20 rapid test would cost maybe $600 million. It's not cost prohibitive and the other big tick for this testing method is that you can vastly expand testing capacity. At the moment you need a specialist pathology lab to run the tests but there are hundreds, perhaps thousands of testing centres that are probably capable of meeting the skill requirements to deliver the rapid test. Dr's, nurses and workplace drug and alcohol services could all be stood up to do the rapid testing. It's a way to vastly expand testing and find 'most' who have the virus or who have had it.

    I would suggest rather than listening to the HC experts that all do their own research. There are plenty of much smarter people than us on here who are putting out very informative information on the benefits of rapid testing. A few threads from the bird below, note these guys should know a little more that the average HC punter.



    Vale delivering 4.5 million Wondfo tests to Brazil



    US MD has put together a very informative thread of where, what how and why rapid testing will be adopted
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.